Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

doi:10.1084/jem.178.3.879

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Brooks, J. M.
	Articles by Rickinson, A. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Brooks, J. M.
	Articles by Rickinson, A. B.


Social Bookmarking

	What's this?

ARTICLES

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

JM Brooks, RJ Murray, WA Thomas, MG Kurilla and AB Rickinson
Department of Cancer Studies, University of Birmingham, UK.

An immunological basis has been postulated for the strong association between at least five subtypes of the HLA-B27 allele (B27.01, .02, .04, .05, and .06) and ankylosing spondylitis, namely that cytotoxic T lymphocyte (CTL) responses are induced against an "arthritogenic" peptide that these different subtypes can all present. This requires a degree of overlap between the peptide binding repertoires of different B27 molecules. The present work, using CTL responses to Epstein-Barr virus (EBV) as a model system in which to identify B27-restricted epitopes, provides the first direct evidence that different disease- related alleles can present the same immunodominant peptide. We first noted that EBV-specific CTL clones, whether from B27.05-, B27.02-, or B27.04-positive donors, were largely subtype-specific in their restriction, recognizing only EBV-transformed B cell lines of the relevant B27 subtype. However, when tested against targets expressing individual EBV proteins from recombinant vaccinia virus vectors, all B27.05-restricted, all B27.02-restricted, and a proportion of B27.04- restricted clones were reactive to the same viral nuclear antigen, Epstein-Barr nuclear antigen (EBNA)3C. In subsequent peptide sensitization assays, all the EBNA3C-specific clones tested and also the EBNA3C-specific component within polyclonal CTL preparations from B27.05-, B27.02-, or B27.04-positive donors recognized the same immunodominant viral peptide RRIYDLIEL (EBNA3C residues 258-266). This sequence accords well with the proposed B27.05 peptide motif and clearly must be accommodated within the different peptide binding grooves of B27.05, B27.02, and B27.04 molecules. Clonal analysis revealed a second component of the B27.04-restricted response that was not shared with other subtypes. This was directed against an EBV latent membrane protein LMP2 epitope whose sequence RRRWRRLTV satisfies some but not all requirements of the B27.05 peptide motif. We conclude that there is indeed a degree of functional overlap between different B27 subtypes in their selection and presentation of CTL epitopes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Narzi, D., Winkler, K., Saidowsky, J., Misselwitz, R., Ziegler, A., Bockmann, R. A., Alexiev, U. (2008). Molecular Determinants of Major Histocompatibility Complex Class I Complex Stability: SHAPING ANTIGENIC FEATURES THROUGH SHORT AND LONG RANGE ELECTROSTATIC INTERACTIONS. J. Biol. Chem. 283: 23093-23103 [Abstract] [Full Text]
Taylor, G. S., Long, H. M., Haigh, T. A., Larsen, M., Brooks, J., Rickinson, A. B. (2006). A Role for Intercellular Antigen Transfer in the Recognition of EBV-Transformed B Cell Lines by EBV Nuclear Antigen-Specific CD4+ T Cells. J. Immunol. 177: 3746-3756 [Abstract] [Full Text]
Ruckert, C., Fiorillo, M. T., Loll, B., Moretti, R., Biesiadka, J., Saenger, W., Ziegler, A., Sorrentino, R., Uchanska-Ziegler, B. (2006). Conformational Dimorphism of Self-peptides and Molecular Mimicry in a Disease-associated HLA-B27 Subtype. J. Biol. Chem. 281: 2306-2316 [Abstract] [Full Text]
Blanco-Gelaz, M. A., Suarez-Alvarez, B., Gonzalez, S., Lopez-Vazquez, A., Martinez-Borra, J., Lopez-Larrea, C. (2006). The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int Immunol 18: 211-220 [Abstract] [Full Text]
Straathof, K. C., Leen, A. M., Buza, E. L., Taylor, G., Huls, M. H., Heslop, H. E., Rooney, C. M., Bollard, C. M. (2005). Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma. J. Immunol. 175: 4137-4147 [Abstract] [Full Text]
Zou, J, Appel, H, Rudwaleit, M, Thiel, A, Sieper, J (2005). Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis. Ann Rheum Dis 64: 722-729 [Abstract] [Full Text]
Fiorillo, M. T., Ruckert, C., Hulsmeyer, M., Sorrentino, R., Saenger, W., Ziegler, A., Uchanska-Ziegler, B. (2005). Allele-dependent Similarity between Viral and Self-peptide Presentation by HLA-B27 Subtypes. J. Biol. Chem. 280: 2962-2971 [Abstract] [Full Text]
Appel, H., Kuon, W., Kuhne, M., Hulsmeyer, M., Kollnberger, S., Kuhlmann, S., Weiss, E., Zeitz, M., Wucherpfennig, K., Bowness, P., Sieper, J. (2004). The Solvent-Inaccessible Cys67 Residue of HLA-B27 Contributes to T Cell Recognition of HLA-B27/Peptide Complexes. J. Immunol. 173: 6564-6573 [Abstract] [Full Text]
Crotzer, V. L., Mabardy, A. S., Weiss, A., Brodsky, F. M. (2004). T Cell Receptor Engagement Leads to Phosphorylation of Clathrin Heavy Chain during Receptor Internalization. J. Exp. Med. 199: 981-991 [Abstract] [Full Text]
Hulsmeyer, M., Fiorillo, M. T., Bettosini, F., Sorrentino, R., Saenger, W., Ziegler, A., Uchanska-Ziegler, B. (2004). Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide. J. Exp. Med. 199: 271-281 [Abstract] [Full Text]
Tao, Q., Yang, J., Huang, H., Swinnen, L. J., Ambinder, R. F. (2002). Conservation of Epstein-Barr Virus Cytotoxic T-Cell Epitopes in Posttransplant Lymphomas : Implications for Immune Therapy. Am. J. Pathol. 160: 1839-1845 [Abstract] [Full Text]
Kuon, W., Holzhutter, H.-G., Appel, H., Grolms, M., Kollnberger, S., Traeder, A., Henklein, P., Weiss, E., Thiel, A., Lauster, R., Bowness, P., Radbruch, A., Kloetzel, P.-M., Sieper, J. (2001). Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases. J. Immunol. 167: 4738-4746 [Abstract] [Full Text]
Lautscham, G., Mayrhofer, S., Taylor, G., Haigh, T., Leese, A., Rickinson, A., Blake, N. (2001). Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for CD8+ T Cell Recognition Reveals a Proteasome-dependent, Transporter Associated with Antigen Processing-independent Pathway. J. Exp. Med. 194: 1053-1068 [Abstract] [Full Text]
Herberts, C. A., Stittelaar, K. J., van der Heeft, E., van Gaans-van den Brink, J., Poelen, M. C. M., Roholl, P. J. M., van Alphen, L. J. W., Melief, C. J. M., de Jong, A. P. J. M., van Els, C. A. C. M. (2001). A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. J. Gen. Virol. 82: 2131-2142 [Abstract] [Full Text]
Chapman, A. L. N., Rickinson, A. B., Thomas, W. A., Jarrett, R. F., Crocker, J., Lee, S. P. (2001). Epstein-Barr Virus-specific Cytotoxic T Lymphocyte Responses in the Blood and Tumor Site of Hodgkin's Disease Patients: Implications for a T-cell-based Therapy. Cancer Res. 61: 6219-6226 [Abstract] [Full Text]
Lee, S. P., Chan, A. T. C., Cheung, S.-T., Thomas, W. A., CroomCarter, D., Dawson, C. W., Tsai, C.-H., Leung, S.-F., Johnson, P. J., Huang, D. P. (2000). CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells. J. Immunol. 165: 573-582 [Abstract] [Full Text]
Crotzer, V. L., Christian, R. E., Brooks, J. M., Shabanowitz, J., Settlage, R. E., Marto, J. A., White, F. M., Rickinson, A. B., Hunt, D. F., Engelhard, V. H. (2000). Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines. J. Immunol. 164: 6120-6129 [Abstract] [Full Text]
Brooks, J. M., Croom-Carter, D. S. G., Leese, A. M., Tierney, R. J., Habeshaw, G., Rickinson, A. B. (2000). Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains. J. Virol. 74: 1801-1809 [Abstract] [Full Text]
Chu, P. G., Chang, K. L., Chen, W.-G., Chen, Y.-Y., Shibata, D., Hayashi, K., Bacchi, C., Bacchi, M., Weiss, L. M. (1999). Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA)-4 Mutation in EBV-Associated Malignancies in Three Different Populations. Am. J. Pathol. 155: 941-947 [Abstract] [Full Text]
Garcia-Peydro, M., Marti, M., Lopez de Castro, J. A. (1999). High T Cell Epitope Sharing Between Two HLA-B27 Subtypes (B*2705 and B*2709) Differentially Associated to Ankylosing Spondylitis. J. Immunol. 163: 2299-2305 [Abstract] [Full Text]
Redchenko, I. V., Rickinson, A. B. (1999). Accessing Epstein-Barr Virus-Specific T-Cell Memory with Peptide-Loaded Dendritic Cells. J. Virol. 73: 334-342 [Abstract] [Full Text]
Brooks, J. M., Colbert, R. A., Mear, J. P., Leese, A. M., Rickinson, A. B. (1998). HLA-B27 Subtype Polymorphism and CTL Epitope Choice: Studies with EBV Peptides Link Immunogenicity with Stability of the B27:Peptide Complex. J. Immunol. 161: 5252-5259 [Abstract] [Full Text]
Paradela, A., Garcia-Peydro, M., Vazquez, J., Rognan, D., Lopez de Castro, J. A. (1998). The Same Natural Ligand Is Involved in Allorecognition of Multiple HLA-B27 Subtypes by a Single T Cell Clone: Role of Peptide and the MHC Molecule in Alloreactivity. J. Immunol. 161: 5481-5490 [Abstract] [Full Text]
Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W. (1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol. 72: 8644-8649 [Abstract] [Full Text]